News and Comments

SAREPTA: What's Going On ?

  Tuesday, April 16, 2013

The requests Sarepta Therapeutics (SRPT) has gotten from the FDA represent a sign of FDA seriousness towards bringing the firm’s drug eteplirsen for Duchenne muscular dystrophy as soon as possible to the children suffering from the debilitating, fast deteriorating disease. The FDA did not wait for the firm to file for early approval, it rather asked Sarepta to bring in more data that would legitimize granting early approval of the first drug ever to claim treating the disabling disease at its root-origin. Investors who should have been optimistic about the FDA initiative sold their shares instead, causing them to lose around 10% of their value.  More...

ImmunoGen Offers New Hopes For Treatment Of Subtypes Of Squamous Cell Carcinomas And Other Difficult-To-Treat Cancers

  Friday, April 12, 2013

 More...

A Quick Response To ARIAD'S (ARIA) Conference Call

  Thursday, April 04, 2013

 More...


Recent Postings


Archive


Tags

Global Cell Therapeutics (GBT) Idenix (IDIX) Vertex (VRTX) BIOMARIN (BMRN) Benlysta (belimumab) Ariad (ARIA) SERES THERAPEUTICS (MCRB) HALOZYME (HALO) Sanofi (SNY) Genentech Intercept (ICPT) Sanofi (SNA) Regeneron (REGN) Revlimid (lenolidamide) AstraZeneca (AZN) Ziofpharm (ZIOP) PORTOLA (PTLA) Tysabri Agenus (AGEN Ionis (IONS) Onyx (ONXX) Human Genome Sciences (HGSI) VANDA (VNDA) Galena (GALE) Sequenom (SQNM) Exelixis (EXEL) Agenus (AGEN) Roche (ROCHE) Theravance (THRX) OSI (OSIP) Ridaforolimus Trastuzumab-DM1 ARGOS (ARGS) AERIE PHARMACEUTICALS Rapamune Roche (RHHBY) ABBVIE (ABBV) NEKTAR (NKTR)) Merck (MRK) ACADIA (ACAD) Bellicum (BLCM) Gilead (GILD) KITE (KITE) ISIS (ISIS) Prolor Biotech (PBTH) SYNTA (SNTA) Auspex (ASPX) Biocryst (BCRX) Spike Therapeutics (ONCE) Alder Biopharmaceuticals (ALDR) galapagos (GLPG) CRISPR Therapeutics (CRSP) Jazz Pharmaceuticals (JAZZ) JUNO (JUNO) Incyte (INCY) GlaxoSmithKline (GSK) Zerenex Amgen (AMGN) ImmunoGen (IMGN) Velcade (bortezomib) Multiple Myeloma INNOVIVA (INVA) Theravance Bio Pharma (TBPH) Micromet (MITI) Vitae Pharmaceuticals (VTAE) Cytokinetics (CYTK) ZALTRAP™ Xoma (XOMA) Sanofi-Aventis (SAN) Mirati Therapeutics (MRTX) ADVENTRIX (ANX) Endometrial Cancer Herceptin REGULUS (RGLS) Elan (ELN) Array Pharmaceuticals (ARRY) C4 Therapeutics KERYX (KERX) CompuGen (CGEN) Telaprevir Prosensa (RNA) PTC Therapeutics (PTCT) Sarepta (SRPT) MODERNA Dendreon (DNDN) NANTKWEST (NK) Abbott Laboratories (ABT) Pluristem (PSTI) Anadys (ANDS) AGOS (ARGS) Dynavax (DVAX) SUNESIS PHARMACEUTICALS (SNSS) Seattle Genetics (SGEN) Intermune (ITMN) Anacor (ANAC) Intrexon (XON) Adaptimmune (ADAP) Valeant Pharmaceuticals International (VRX) IDERA (IDRA) Illumina (ILMN) Aimmune Therapeutics (AIMT) NOVOCURE (NVCR) Human Longevity (HLI) Alnylam (ALNY) GUARDIAN HEALTH Editas (EDIT) Sangamo (SGMO) Ocular Therapeutix (OCUL) Biogen Idec (BIIB) Bristol-Myers Squibb (BMY) ARCA (ABIO) Inovio (INO) TOKAI (TKAOI) RenenxBio (RGNX) CEMPRA (CEMP) Advaxis (ADXS)